191170-76-0

Basic information

• Product Name: BENZYL 4-BROMOPHENETHYLCARBAMATE
• Synonyms: BENZYL 4-BROMOPHENETHYLCARBAMATE;WIUKEHNGQSSRHQ-UHFFFAOYSA-N
• CAS NO: 191170-76-0
• Molecular Formula: C₁₆H₁₆BrNO₂
• Molecular Weight: 334.21
• Mol File: 191170-76-0.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 473.7±38.0 °C(Predicted)
• Appearance: /
• Density: 1.367±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 12.38±0.46(Predicted)
• CAS DataBase Reference: BENZYL 4-BROMOPHENETHYLCARBAMATE(CAS DataBase Reference)
• NIST Chemistry Reference: BENZYL 4-BROMOPHENETHYLCARBAMATE(191170-76-0)
• EPA Substance Registry System: BENZYL 4-BROMOPHENETHYLCARBAMATE(191170-76-0)

Safety Data

• Hazardous Substances Data: 191170-76-0(Hazardous Substances Data)

Upstream product

• 39260-89-4 2-(4-bromophenyl)-1-aminoethane hydrochloride 
• 501-53-1 benzyl chloroformate 
• 73918-56-6 4-Bromophenethylamine 
• 100-51-6 benzyl alcohol 
• 4654-39-1 4-bromophenethanol 
• 439585-11-2 N-[[[(benzyloxy)carbonyl]azanide]sulfonyl]-N,N-diethylethylammonium 

Downstream Products

• 1146546-95-3 C₂₇H₂₉NO₄ 
• 1146547-00-3 C₂₈H₃₁NO₅ 
• 132224-93-2 [(4-cyanophenyl)methyl]methanamine 
• 625127-09-5 benzyl 7-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate 
• 2126812-29-9 benzyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)carbamate 

Relevant articles and documents

TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS

The present invention provides triazolotriazine derivatives of formula (1) as A2A receptor antagonists. Compounds of formula (1) and pharmaceutical compositions including the compounds can be used for the treatment of disorders related to A2A receptor hyp

THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

The disclosure relates to inhibitors of USP28 and/or USP25 useful in the treatment of cancers, inflammation, autoimmune diseases, and infectious diseases, having the Formula: (I), where R1, R2, R3, R4, R4', R5, R6, X, and n are described herein.

CCR10 ANTAGONISTS

The invention relates to a compound of formula (I) or a tautomer thereof or a pharmaceutically acceptable salt thereof, wherein R1 to R11, W, X, Y, Z, and n are as defined herein. The invention also relates to methods of using the compounds of formula (I) and compositions thereof to treat various diseases and disorders in a patient. The invention also relates to processes for preparing the compounds of formula (I) and intermediates useful in these processes.